Chosunbiz5 天
Daimbio secures 12 billion won Series A funding for anticancer and brain disease drugs
The new drug development corporation Daimbio announced on the 25th that it has completed a series A funding round worth 12 ...
조선일보24 天
K-Digital healthcare draws UK and Japan interest through AI and big data innovation
LifeARC is a medical research organization in the UK that serves a similar role to South Korea's National New Drug Development Project Group (KDDF). LifeARC has conducted preclinical and phase 1 ...